768 results on '"TET"'
Search Results
252. DNA Modifications and Neurological Disorders.
- Author
-
Weng, Yi-Lan, An, Ran, Shin, Jaehoon, Song, Hongjun, and Ming, Guo-li
- Subjects
DNA methylation ,NEUROLOGICAL disorders ,BRAIN anatomy ,CYTOSINE ,DNA modification & restriction ,EPIGENETICS - Abstract
Mounting evidence has recently underscored the importance of DNA methylation in normal brain functions. DNA methylation machineries are responsible for dynamic regulation of methylation patterns in discrete brain regions. In addition to methylation of cytosines in genomic DNA (5-methylcytosine; 5mC), other forms of modified cytosines, such as 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxylcytosine, can potentially act as epigenetic marks that regulate gene expression. Importantly, epigenetic modifications require cognate binding proteins to read and translate information into gene expression regulation. Abnormal or incorrect interpretation of DNA methylation patterns can cause devastating consequences, including mental illnesses and neurological disorders. Although DNA methylation was generally considered to be a stable epigenetic mark in post-mitotic cells, recent studies have revealed dynamic DNA modifications in neurons. Such reversibility of 5mC sheds light on potential mechanisms underlying some neurological disorders and suggests a new route to correct aberrant methylation patterns associated with these disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
253. Alterations of 5-Hydroxymethylcytosine in Human Cancers.
- Author
-
Mariani, Christopher J., Madzo, Jozef, Moen, Erika L., Yesilkanal, Ali, and Godley, Lucy A.
- Subjects
- *
CANCER invasiveness , *DATABASES , *TUMORS , *GENOMICS - Abstract
Prior to 2009, 5-methylcytosine (5-mC) was thought to be the only biologically significant cytosine modification in mammalian DNA. With the discovery of the TET enzymes, which convert 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC), however, intense interest has emerged in determining the biological function of 5-hmC. Here, we review the techniques used to study 5-hmC and evidence that alterations to 5-hmC physiology play a functional role in the molecular pathogenesis of human cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
254. Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a.
- Author
-
Zhang, Pei, Huang, Bihui, Xu, Xiangru, and Sessa, William C.
- Subjects
- *
CHROMOSOMAL translocation , *THYMIDINE , *DNA glycosylases , *DEMETHYLATION , *MICRORNA , *EPIGENETICS - Abstract
Highlights: [•] Ten-eleven translocation (TET) enzymes convert 5-mC to 5-hmC. [•] 5hmC can be repaired by thymine DNA glycosylase (TDG). [•] miR-29a targets to Tet1-3 and TDG mRNA and influences global 5hmC. [•] miR-29 can modulate epigenetics by targeting Tets and TDG. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
255. Genome-wide distribution of DNA methylation and DNA demethylation and related chromatin regulators in cancer
- Author
-
Jiang, Yiqun, Liu, Shuang, Chen, Xiang, Cao, Ya, and Tao, Yongguang
- Subjects
- *
DNA methylation , *CHROMATIN , *GENETIC regulation , *GENE expression , *CANCER genetics , *EPIGENETICS , *GENETIC transcription - Abstract
Abstract: DNA methylation plays an important role in the regulation of gene expression, as it is the first epigenetic modification to take place on a given DNA strand. Several factors may directly or indirectly regulate the dynamic distribution of DNA methylation and demethylation between intergenic and intragenic gene regions, thereby controlling gene expression. CpG islands have direct implications for the understanding of DNA methylation patterns in normal conditions and in some common disease states, including cancer. Here, we summarize several recent studies on the genome-wide distribution of DNA methylation and demethylation and their related factors, and we discuss the potential of DNA methylation and demethylation patterns to contribute to gene transcription patterns in tumorigenesis. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
256. Epigenetic remodeling by vitamin C potentiates plasma cell differentiation.
- Author
-
Chen HY, Almonte-Loya A, Lay FY, Hsu M, Johnson E, González-Avalos E, Yin J, Bruno RS, Ma Q, Ghoneim HE, Wozniak DJ, Harrison FE, and Lio CJ
- Subjects
- Animals, Cell Differentiation, Epigenesis, Genetic, Epigenomics, Humans, Mice, Ascorbic Acid pharmacology, Vitamins
- Abstract
Ascorbate (vitamin C) is an essential micronutrient in humans. The severe chronic deficiency of ascorbate, termed scurvy, has long been associated with increased susceptibility to infections. How ascorbate affects the immune system at the cellular and molecular levels remained unclear. From a micronutrient analysis, we identified ascorbate as a potent enhancer for antibody response by facilitating the IL-21/STAT3-dependent plasma cell differentiation in mouse and human B cells. The effect of ascorbate is unique as other antioxidants failed to promote plasma cell differentiation. Ascorbate is especially critical during early B cell activation by poising the cells to plasma cell lineage without affecting the proximal IL-21/STAT3 signaling and the overall transcriptome. As a cofactor for epigenetic enzymes, ascorbate facilitates TET2/3-mediated DNA modification and demethylation of multiple elements at the Prdm1 locus. DNA demethylation augments STAT3 association at the Prdm1 promoter and a downstream enhancer, thus ensuring efficient gene expression and plasma cell differentiation. The results suggest that an adequate level of ascorbate is required for antibody response and highlight how micronutrients may regulate the activity of epigenetic enzymes to regulate gene expression. Our findings imply that epigenetic enzymes can function as sensors to gauge the availability of metabolites and influence cell fate decisions., Competing Interests: HC, AA, FL, MH, EJ, EG, JY, RB, QM, HG, DW, FH, CL No competing interests declared, (© 2022, Chen, Almonte-Loya et al.)
- Published
- 2022
- Full Text
- View/download PDF
257. 5-methylcytosine turnover: Mechanisms and therapeutic implications in cancer.
- Author
-
Turpin M and Salbert G
- Abstract
DNA methylation at the fifth position of cytosine (5mC) is one of the most studied epigenetic mechanisms essential for the control of gene expression and for many other biological processes including genomic imprinting, X chromosome inactivation and genome stability. Over the last years, accumulating evidence suggest that DNA methylation is a highly dynamic mechanism driven by a balance between methylation by DNMTs and TET-mediated demethylation processes. However, one of the main challenges is to understand the dynamics underlying steady state DNA methylation levels. In this review article, we give an overview of the latest advances highlighting DNA methylation as a dynamic cycling process with a continuous turnover of cytosine modifications. We describe the cooperative actions of DNMT and TET enzymes which combine with many additional parameters including chromatin environment and protein partners to govern 5mC turnover. We also discuss how mathematical models can be used to address variable methylation levels during development and explain cell-type epigenetic heterogeneity locally but also at the genome scale. Finally, we review the therapeutic implications of these discoveries with the use of both epigenetic clocks as predictors and the development of epidrugs that target the DNA methylation/demethylation machinery. Together, these discoveries unveil with unprecedented detail how dynamic is DNA methylation during development, underlying the establishment of heterogeneous DNA methylation landscapes which could be altered in aging, diseases and cancer., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Turpin and Salbert.)
- Published
- 2022
- Full Text
- View/download PDF
258. Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth
- Author
-
Cao, Liang-qi, Yang, Xue-wei, Chen, Yu-bin, Zhang, Da-wei, Jiang, Xiao-Feng, and Xue, Ping
- Published
- 2019
- Full Text
- View/download PDF
259. Hyperglycemia affects global 5-methylcytosine and 5-hydroxymethylcytosine in blood genomic DNA through upregulation of SIRT6 and TETs
- Author
-
Yuan, Er-Feng, Yang, Ying, Cheng, Lin, Deng, Xujing, Chen, Shao-Min, Zhou, Xin, and Liu, Song-Mei
- Published
- 2019
- Full Text
- View/download PDF
260. Mechanisms of DNA methylation and demethylation in mammals
- Author
-
Auclair, Ghislain and Weber, Michael
- Subjects
- *
DNA methylation , *DEMETHYLATION , *MAMMAL embryology , *GENETIC regulation , *DEVELOPMENTAL cytology , *BIOCHEMISTRY - Abstract
Abstract: Cytosine methylation is an epigenetically propagated DNA modification that can modify how the DNA molecule is recognized and expressed. DNA methylation undergoes extensive reprogramming during mammalian embryogenesis and is directly linked to the regulation of pluripotency and cellular identity. Studying its regulation is also important for a better understanding of the many diseases that show epigenetic deregulations, in particular, cancer. In the recent years, a lot of progress has been made to characterize the profiles of DNA methylation at the genome level, which revealed that patterns of DNA methylation are highly dynamic between cell types. Here, we discuss the importance of DNA methylation for genome regulation and the mechanisms that remodel the DNA methylome during mammalian development, in particular the involvement of the rediscovered modified base 5-hydroxymethylcytosine. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
261. Phylogenetic diversity, antibiotic resistance and virulence traits of Aeromonas spp. from untreated waters for human consumption
- Author
-
Carvalho, Maria João, Martínez-Murcia, Antonio, Esteves, Ana Cristina, Correia, António, and Saavedra, Maria José
- Subjects
- *
DRUG resistance in microorganisms , *PHYLOGENY , *VIRULENCE of bacteria , *AEROMONAS , *AQUATIC microbiology , *WATER pollution , *TETRACYCLINE , *PROTEOLYSIS , *LIPOLYSIS , *BACTERIA - Abstract
Abstract: It is well known that water constitutes an important contamination route for microorganisms. This is especially true for Aeromonas which are widespread in untreated and treated waters. In this study, Portuguese untreated waters not regularly monitored were screened for the presence and diversity of aeromonads. A total of 206 isolates were discriminated by RAPD-PCR and 80 distinct strains were identified by gyrB based phylogenetic analysis. The most frequently detected species were Aeromonas hydrophila, Aeromonas bestiarum and Aeromonas media. The antibiotic susceptibility profile of these strains was determined and showed a typical profile of the genus. Nonetheless, the percentage of resistant strains to tetracycline, chloramphenicol and/or trimethoprim/sulfamethoxazole was lower than that reported for clinical isolates and isolates recovered from aquacultures and other environments historically subjected to antibiotic contamination. This suggests that the existence of such pressures in those environments selects for resistant Aeromonas. A similar trend for integron presence was found. Genes coding for CphA and TEM, and tet(A), (E), (C) or (D) genes were found in 28%, 1%, and 10% of the strains, respectively. 10% of the strains contained an integron. Variable regions of seven class 1 integrons and one class 2 integron were characterised. Furthermore, strains displayed virulence related phenotypes such as extracellular lipolytic and proteolytic activities as well as aerolysin related genes (43% of strains). The ascV and aexT genes were found in 16% and 3% of strains respectively and, in some cases, concomitantly in the same specimen. This study shows that diverse Aeromonas spp. presenting distinct antibiotic resistance features and putative virulence traits are frequently present in waters for human and animal consumption in Portugal. Genes associated to antibiotic resistance and microbial virulence previously identified in organisms with human health significance were detected in these aeromonads, suggesting that these waters may act as a pivotal route for infections. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
262. Low values of 5-hydroxymethylcytosine (5hmC), the 'sixth base,' are associated with anaplasia in human brain tumors.
- Author
-
Kraus, Theo F.J., Globisch, Daniel, Wagner, Mirko, Eigenbrod, Sabina, Widmann, David, Münzel, Martin, Müller, Markus, Pfaffeneder, Toni, Hackner, Benjamin, Feiden, Wolfgang, Schüller, Ulrich, Carell, Thomas, and Kretzschmar, Hans A.
- Abstract
5-Methylcytosine (5mC) in genomic DNA has important epigenetic functions in embryonic development and tumor biology. 5-Hydroxymethylcytosine (5hmC) is generated from 5mC by the action of the TET (Ten-Eleven-Translocation) enzymes and may be an intermediate to further oxidation and finally demethylation of 5mC. We have used immunohistochemistry (IHC) and isotope-based liquid chromatography mass spectrometry (LC-MS) to investigate the presence and distribution of 5hmC in human brain and brain tumors. In the normal adult brain, IHC identified 61.5% 5hmC positive cells in the cortex and 32.4% 5hmC in white matter (WM) areas. In tumors, positive staining of cells ranged from 1.1% in glioblastomas (GBMs) (WHO Grade IV) to 8.9% in Grade I gliomas (pilocytic astrocytomas). In the normal adult human brain, LC-MS also showed highest values in cortical areas (1.17% 5hmC/dG [deoxyguanosine]), in the cerebral WM we measured around 0.70% 5hmC/dG. 5hmC levels were related to tumor differentiation, ranging from lowest values of 0.078% 5hmC/dG in GBMs (WHO Grade IV) to 0.24% 5hmC/dG in WHO Grade II diffuse astrocytomas. 5hmC measurements were unrelated to 5mC values. We find that the number of 5hmC positive cells and the amount of 5hmC/dG in the genome that has been proposed to be related to pluripotency and lineage commitment in embryonic stem cells is also associated with brain tumor differentiation and anaplasia. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
263. Tet family proteins and 5-hydroxymethylcytosine in development and disease.
- Author
-
Li Tan and Yujiang Geno Shi
- Subjects
- *
PROTEINS , *METHYLCYTOSINE , *DNA methylation , *CYTOSINE , *EPIGENETICS , *GROWTH , *CANCER - Abstract
Over the past few decades, DNA methylation at the 5-position of cytosine (5-methylcytosine, 5mC) has emerged as an important epigenetic modification that plays essential roles in development, aging and disease. However, the mechanisms controlling 5mC dynamics remain elusive. Recent studies have shown that ten-eleven translocation (Tet) proteins can catalyze 5mC oxidation and generate 5mC derivatives, including 5- hydroxymethylcytosine (5hmC). The exciting discovery of these novel 5mC derivatives has begun to shed light on the dynamic nature of 5mC, and emerging evidence has shown that Tet family proteins and 5hmC are involved in normal development as well as in many diseases. In this Primer we provide an overview of the role of Tet family proteins and 5hmC in development and cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
264. Conditional Allele Mouse Planner (CAMP): software to facilitate the planning and design of breeding strategies involving mice with conditional alleles.
- Author
-
Hoffert, Jason, Pisitkun, Trairak, and Miller, R.
- Abstract
Transgenic and conditional knockout mouse models play an important role in biomedical research and their use has grown exponentially in the last 5-10 years. Generating conditional knockouts often requires breeding multiple alleles onto the background of a single mouse or group of mice. Breeding these mice depends on parental genotype, litter size, transmission frequency, and the number of breeding rounds. Therefore, a well planned breeding strategy is critical for keeping costs to a minimum. However, designing a viable breeding strategy can be challenging. With so many different variables this would be an ideal task for a computer program. To facilitate this process, we created a Java-based program called Conditional Allele Mouse Planner (CAMP). CAMP is designed to provide an estimate of the number of breeders, amount of time, and costs associated with generating mice of a particular genotype. We provide a description of CAMP, how to use it, and offer it freely as an application. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
265. Biochemistry of Bacterial Multidrug Efflux Pumps.
- Author
-
Kumar, Sanath and Varela, Manuel F.
- Subjects
- *
MULTIDRUG resistance , *BIOCHEMISTRY , *ANTI-infective agents , *PATHOGENIC microorganisms , *BACTERIAL diseases , *DRUG efficacy , *PATHOGENIC bacteria - Abstract
Bacterial pathogens that are multi-drug resistant compromise the effectiveness of treatment when they are the causative agents of infectious disease. These multi-drug resistance mechanisms allow bacteria to survive in the presence of clinically useful antimicrobial agents, thus reducing the efficacy of chemotherapy towards infectious disease. Importantly, active multi-drug efflux is a major mechanism for bacterial pathogen drug resistance. Therefore, because of their overwhelming presence in bacterial pathogens, these active multi-drug efflux mechanisms remain a major area of intense study, so that ultimately measures may be discovered to inhibit these active multi-drug efflux pumps. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
266. A Self-Tuning Inductive Powering System for Biomedical Implants.
- Author
-
Carta, R., Thoné, J., Gosset, G., Cogels, G., Flandre, D., and Puers, R.
- Abstract
Abstract: This paper describes the design and implementation of a self-tuning inductive powering system conceived for biomedical applications. The circuit operates at 1MHz and delivers 380 mW to the implant with an efficiency of 50%, at a distance of 1cm. Absorption modulation is used to monitor the circuit parameters allowing the system to deal with distance increases up to 5cm as well as small coil misalignments. The automatic-tuning system adjusts the configuration of the coil driver depending on the self-monitored coupling, acting on a bank of switchable capacitors with a pattern defined by the received data. It is demonstrated that the implemented tuning strategy boosts the transmitted power by a factor two. In addition, the combination of tuning and smart power regulation was proven to sensibly increase the system efficiency by maintaining a constant energy level at the secondary. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
267. Hydroxylation mediates chromatin demethylation.
- Author
-
Tsukada, Yu-ichi
- Subjects
- *
METHYLATION , *HISTONES , *CHROMATIN , *HYDROXYLATION , *KETOGLUTARATE dehydrogenase - Abstract
Methylation of DNA and histones in chromatin has been implicated in numerous biological processes. For many years, methylation has been recognized as static and stable modification, as compared with other covalent modifications of chromatin. Recently, however, several mechanisms have been demonstrated to be involved in demethylation of chromatin, suggesting that chromatin methylation is more dynamically regulated. One chemical reaction that mediates demethylation of both DNA and histones is hydroxylation, catalysed by Fe(II) and α-ketoglutarate (KG)-dependent hydroxylase/dioxygenase. Given that methylation of chromatin is an important epigenetic mark involved in fundamental biological processes such as cell fate determination, understanding how chromatin methylation is dynamically regulated has implications for human diseases and regenerative medicine. [ABSTRACT FROM PUBLISHER]
- Published
- 2012
- Full Text
- View/download PDF
268. Hypothesis.
- Published
- 2011
- Full Text
- View/download PDF
269. Distribution and transferability of tetracycline resistance determinants in Escherichia coli isolated from meat and meat products
- Author
-
Koo, Hyon-Ji and Woo, Gun-Jo
- Subjects
- *
TETRACYCLINE , *ESCHERICHIA coli , *MEAT , *HYGIENE products , *FOOD quality , *ANTI-infective agents , *DRUG resistance , *OXYTETRACYCLINE , *GEL electrophoresis - Abstract
Abstract: Escherichia coli is used to assess the hygienic quality of food products and the dissemination of antimicrobial resistance. In particular, tetracycline-resistant E. coli can be chosen as an indicator of antibiotic resistant bacteria because it has a high frequency of occurrence. The purpose of this study was to investigate the distribution and transfer of tetracycline resistance determinants in meatborne E. coli. A total of 121 tetracycline-resistant E. coli isolates were collected from meat and meat products (raw meat, fish, and processed foods) from 2004 to 2006 in Korea. Among these isolates, tet(A) (52.4%) was the most frequent tetracycline resistance determinant, followed by tet(B) (41.3%), whereas tet(C) (1.7%) and tet(D) (0.8%) were less frequently identified. Two isolates (1.6%) contained two tet genes simultaneously, tet(A) and tet(B). Minimal inhibitory concentrations (MICs) to tetracycline family antibiotics, such as tetracycline, minocycline, doxycycline, oxytetracycline, and chlortetracycline were higher for isolates carrying the tet(B) gene compared to isolates carrying tet(A) (P <0.0001). Conjugation experiments were performed by the broth mating method; 119 isolates (98.3%) containing at least one of the tet genes were shown to transfer tetracycline resistance to recipient E. coli J53. Also, we observed high diversity of tetracycline-resistant E. coli isolates in meat and meat products in Korea by using XbaI pulsed-field gel electrophoresis (PFGE) typing. This study suggests that the high prevalence of tetracycline-resistant E. coli in meat may be due to the high transferability of tet determinants. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
270. Antibiotic Susceptibility of Bifidobacterial Strains Distributed in the Japanese Market.
- Author
-
Jin-Zhong Xiao, Takahashi, Sachiko, Odamaki, Toshitaka, Yaeshima, Tomoko, and Twatsuki, Keiji
- Subjects
- *
ANTIBIOTICS , *MICROBIAL sensitivity tests , *PROBIOTICS , *AMPICILLIN , *CHLORAMPHENICOL , *VANCOMYCIN - Abstract
The article presents a study which analyzes the antibiotic susceptibility of bifidobacterial strains spread in the Japanese market. The study used the broth microdilution method to test 23 strains such as probiotic isolates from foods, pharmaceuticals, and supplements. Moreover, it found that strains were susceptible to ampicillin, chloramphenicol and vancomycin, as well as, linezolid.
- Published
- 2010
- Full Text
- View/download PDF
271. TET
- Author
-
Rédei, George P.
- Published
- 2008
- Full Text
- View/download PDF
272. Thousand words about cervical cancer and epigenetics.
- Author
-
Bronowicka-Kłys, Dorota E., Pawlik, Patrycja, and Jagodziński, Paweł P.
- Subjects
- *
EPIGENETICS , *CERVICAL cancer treatment , *DNA methylation , *GENE expression , *CANCER genetics - Abstract
Epigenetic modifications include DNA methylation, DNA demethylation along with the major role fulfilled by TET protein. Epigenetic modifications refer to the regulation of gene expression without the alteration of the DNA sequence. Some of the most common epigenetic modifications include DNA methylation and demethylation, as well as the functional role of TET proteins. Epigenetic alterations are heritable traits, therefore one of the key elements to understanding the mechanisms of cancer development is to further our knowledge on the role and function of epigenetic modifications. This mini-review takes into consideration the overview of the literature on the impact of epigenetic changes in cancer development, especially in the development of CC. Researchers believe that certain compounds are capable of inhibiting the process of DNA methylation and may play an important role in future cancer therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
273. DNA Methylation and Detoxification in the Earthworm Lumbricus terrestris Exposed to Cadmium and the DNA Demethylation Agent 5-aza-2′-deoxycytidine.
- Author
-
Aigner, Gerhard P., Nenning, Pamela, Fiechtner, Birgit, Šrut, Maja, and Höckner, Martina
- Subjects
DNA methylation ,DNA demethylation ,EARTHWORMS ,HEAVY metal toxicology ,CADMIUM ,PHYTOCHELATINS ,METALLOTHIONEIN ,HISTONE methylation - Abstract
Earthworms are well-established model organisms for testing the effects of heavy metal pollution. How DNA methylation affects cadmium (Cd) detoxification processes such as the expression of metallothionein 2 (MT2), however, is largely unknown. We therefore exposed Lumbricus terrestris to 200 mg concentrations of Cd and 5-aza-2′-deoxycytidine (Aza), a demethylating agent, and sampled tissue and coelomocytes, cells of the innate immune system, for 48 h. MT2 transcription significantly increased in the Cd- and Cd-Aza-treated groups. In tissue samples, a significant decrease in MT2 in the Aza-treated group was detected, showing that Aza treatment inhibits basal MT2 gene activity but has no effect on Cd-induced MT2 levels. Although Cd repressed the gene expression of DNA-(cytosine-5)-methyltransferase-1 (DNMT1), which is responsible for maintaining DNA methylation, DNMT activity was unchanged, meaning that methylation maintenance was not affected in coelomocytes. The treatment did not influence DNMT3, which mediates de novo methylation, TET gene expression, which orchestrates demethylation, and global levels of hydroxymethylcytosine (5hmC), a product of the demethylation process. Taken together, this study indicates that Aza inhibits basal gene activity, in contrast to Cd-induced MT2 gene expression, but does not affect global DNA methylation. We therefore conclude that Cd detoxification based on the induction of MT2 does not relate to DNA methylation changes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
274. Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2.
- Author
-
Zhao, Huanhuan, Lu, Jun, Yan, Tong, Han, Fei, Sun, Jie, Yin, Xiaolin, Chen, Liting, Shen, Chao, Wunderlich, Mark, Yun, Weina, Yang, Lingling, Chen, Liyun, Su, Dan, Bohlander, Stefan K., Wang, Fudi, Mulloy, James C., Li, Chong, Chen, Jianjun, Huang, He, and Jiang, Xi
- Abstract
Acute myeloid leukemia (AML) is a genetically heterogeneous and frequently fatal malignancy. The ten-eleven translocation (TET)-mediated DNA demethylation is known to be critically associated with AML pathogenesis. Through chemical compound screening, we find that the opioid receptor agonist, loperamide hydrochloride (OPA1), significantly suppresses AML cell viability. The potential therapeutic effects of opioid receptor agonists, especially OPA1, are verified in AML cells in vitro and mouse and human AML models in vivo. OPA1-induced activation of OPRM1 signaling enhances the transcription of TET2 and thus activates both catalytic-dependent and -independent functions of TET2. Notably, AMLs with TET2 mutations or chemotherapy resistance are sensitive to OPA1 as well. Our results reveal the OPRM1- TET2 regulatory axis in AML and suggest that opioid agonists, particularly OPA1, a US Food and Drug Administration (FDA)-approved antidiarrheal drug, have therapeutic potential in AML, especially in TET2 -mutated and chemotherapy-resistant AMLs, which have a poor prognosis. [Display omitted] • Opioid signaling agonists have therapeutic potential in AML • Opioid signaling activates TET2 transcription and increases global 5hmC level • TET2 enzymatic activity-dependent and -independent functions in OPA1 response • The OPRM1- TET2 regulatory axis is involved in AML The regulatory pathway of the TET-mediated DNA demethylation remains unclear in acute myeloid leukemia (AML). Zhao et al. report the beneficial therapeutic effects of opioid-receptor agonists, especially loperamide hydrochloride (OPA1) in AML, as OPA1 induces the activation of the OPRM1-TET2 regulatory axis in TET2-mutated and chemotherapy-resistant AML. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
275. Decoding DNA methylation in epigenetics of multiple myeloma.
- Author
-
Yang, Ting, Liu, Xiaobo, Kumar, Shaji K., Jin, Fengyan, and Dai, Yun
- Abstract
Dysregulation of DNA methylation in B cells has been observed during their neoplastic transformation and therefore closely associated with various B-cell malignancies including multiple myeloma (MM), a malignancy of terminally differentiated plasma cells. Emerging evidence has unveiled pronounced alterations in DNA methylation in MM, including both global and gene-specific changes that can affect genome stability and gene transcription. Moreover, dysregulated expression of DNA methylation-modifying enzymes has been related with myelomagenesis, disease progression, and poor prognosis. However, the functional roles of the epigenetic abnormalities involving DNA methylation in MM remain elusive. In this article, we review current understanding of the alterations in DNA methylome and DNA methylation modifiers in MM, particularly focusing on DNA methyltransferases (DNMTs) and tet methylcytosine dioxygenases (TETs). We also discuss how these DNA methylation modifiers may be regulated and function in MM cells, therefore providing a rationale for developing novel epigenetic therapies targeting DNA methylation in MM. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
276. Technical note: Occurrence in fecal microbiota of genes conferring resistance to both macrolide-lincosamide-streptogramin B and tetracyclines concomitant with feeding of beef cattle with tylosin.
- Author
-
Chen, J., Fluharty, F. L., St-Pierre, N., Morrison, M., and Yu, Z.
- Subjects
- *
BEEF cattle breeding , *ANIMAL culture , *ZOOLOGICAL research , *BIOLOGICAL research , *ECONOMIC zoology - Abstract
Development of antimicrobial resistance in food animals receiving antimicrobials has been well documented among bacterial isolates, especially pathogens, but information on development of antimicrobial resistance at the microbial community level during long-term feeding of antimicrobials is lacking. The objective of this study was to examine the association between inclusion of tylosin in feed and occurrence of resistance to macrolide-lincosamide-streptogramjn B (MLSB) in the entire fecal microbial communities of beef cattle over a feeding study of 168 d. A completely randomized design included 6 pens housed together in 1 barn, with each pen housing 10 to 11 steers. The control and tylosin groups each had 3 pens, with the former receiving no antimicrobial whereas the latter received both tylosin and monensin (11 and 29.9 mgI kg of feed, respectively, DM) in feed. The abundance of genes conferring resistance to MLSB (erm genes) and tetracyclines (tet genes) were quantified using class-specific, real-time PCR assays. The abundances of erm and tet genes were analyzed with pens as experimental units using the MIXED procedure of SAS. Correlations between abundance of different resistance genes were calculated using the CORR procedure of SAS. We identified 4 classes (B, F, T, and X) of erm genes in fresh fecal samples collected at wk 2, 17, and 21 of feeding. From wk 2 to 17, the abundance of erm(T) and erm(X) increased (P< 0.05), whereas that of erm(B) and erm(F) did not. The abundance of the erm genes did not further change from wk 17 to 21. The tet(A/C), tet(G), and tet gene variants encoding ribosomal protection proteins (including classes M, 0, P, Q, S, T, and W) appeared to be co-selected by tylosin feeding. Such co-selection of multiresistance at community level by one antimicrobial drug used in animals has the important implication that future studies should examine resistance to not only the antimicrobials used in animals, but also other antimicrobials, especially those used in human medicine, to fully assess the potential risk associated with antimicrobial use in animals. Both the erm and tet genes appeared to be disseminated among the microbial populations in all steers housed together. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
277. DNA methylation/hydroxymethylation in melanoma
- Author
-
Christine G. Lian, Siqi Fu, Qianjin Lu, Huiming Zhang, and Haijing Wu
- Subjects
0301 basic medicine ,DNA Hydroxymethylation ,business.industry ,Melanoma ,epigenetic therapy ,Review ,medicine.disease ,03 medical and health sciences ,5-hmC ,030104 developmental biology ,DNA demethylation ,Oncology ,DNA methylation ,Immunology ,melanoma ,medicine ,Cancer research ,Epigenetics ,business ,neoplasms ,5-mC ,Gene ,TET ,Epigenetic therapy ,Epigenomics - Abstract
// Siqi Fu 1, * , Haijing Wu 1, * , Huiming Zhang 1 , Christine G. Lian 2 and Qianjin Lu 1 1 Department of Dermatology, Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Medical Epigenomics, Changsha, Hunan, China 2 Program in Dermatopathology, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA * These authors have contributed equally to this work Correspondence to: Lu Qianjin, email: qianlu5860@gmail.com Keywords: melanoma, 5-hmC, 5-mC, epigenetic therapy, TET Received: March 02, 2017 Accepted: May 03, 2017 Published: May 30, 2017 ABSTRACT Melanoma is a malignant tumor of melanocytes and is considered to be the most aggressive cancer among all skin diseases. The pathogenesis of melanoma has not been well documented, which may restrict the research and development of biomarkers and therapies. To date, several genetic and epigenetic factors have been identified as contributing to the development and progression of melanoma. Besides the findings on genetic susceptibilities, the recent progress in epigenetic studies has revealed that loss of the DNA hydroxymethylation mark, 5-hydroxymethylcytosine (5-hmC), along with high levels of DNA methylation at promoter regions of several tumor suppressor genes in melanoma, may serve as biomarkers for melanoma. Moreover, 5-Aza-2′-deoxycytidine, an epigenetic modifier causing DNA demethylation, and ten-eleven translocation family dioxygenase (TET), which catalyzes the generation of 5-hmC, demonstrate therapeutic potential in melanoma treatment. In this review, we will summarize the latest progress in research on DNA methylation/hydroxymethylation in melanoma, and we will discuss and provide insight for epigenetic biomarkers and therapies for melanoma. Particularly, we will discuss the role of DNA hydroxymethylation in melanoma infiltrating immune cells, which may also serve as a potential target for melanoma treatment.
- Published
- 2017
- Full Text
- View/download PDF
278. Comparison of fertility following use of one versus two intravaginal progesterone inserts in dairy cows without a CL during a synchronization protocol before timed AI or timed embryo transfer
- Author
-
Milo C. Wiltbank, M. H. C. Pereira, C.P. Sanches, José Luiz Moraes Vasconcelos, T.G. Guida, Universidade Estadual Paulista (Unesp), and University of Wisconsin
- Subjects
0301 basic medicine ,medicine.medical_specialty ,media_common.quotation_subject ,Fertility ,CIDR ,03 medical and health sciences ,Follicle ,Animal science ,Food Animals ,Pregnancy ,Lactation ,Internal medicine ,medicine ,Animals ,Small Animals ,Ovulation ,Insemination, Artificial ,Progesterone ,media_common ,Equine ,business.industry ,0402 animal and dairy science ,04 agricultural and veterinary sciences ,Embryo Transfer ,medicine.disease ,Oocyte ,040201 dairy & animal science ,Embryo transfer ,Administration, Intravaginal ,030104 developmental biology ,medicine.anatomical_structure ,Endocrinology ,TAI ,Cattle ,Female ,Animal Science and Zoology ,Implant ,Estrus Synchronization ,business ,TET - Abstract
Made available in DSpace on 2018-12-11T16:44:37Z (GMT). No. of bitstreams: 0 Previous issue date: 2017-02-01 National Institute of Food and Agriculture The objective was to evaluate the effect of increased progesterone (P4) during preovulatory follicle growth during timed AI (TAI) or timed embryo transfer (TET) protocols. Lactating dairy cows with no CL and low circulating P4 (≤1.0 ng/mL) were submitted to a protocol using one or two intravaginal P4 implants (controlled intravaginal releasing device [CIDRs]), and were bred to TAI or TET. The low P4 cows for this experiment were identified on nine farms, four utilized TAI (n = 326 of 1160 cows examined), and five utilized TET (n = 445 of 1396). All cows were synchronized by insertion of P4 implant(s) (CIDR[s]) at start of protocol (Day −11) and simultaneous treatment with 2 mg of E2-benzoate. After 7 days, cows were treated with PGF (Day −4) and 2 days later treated with 1.0-mg E2-cypionate and CIDR(s) were removed (Day −2). Cows received TAI on Day 0 or TET on Day 7. Cows were randomly assigned to receive either one or two CIDRs on Day −11 until Day −2 (1CIDR vs. 2CIDR). Presence of CL was determined by ultrasound on Day −11 and Day 7 after protocol (to determine ovulation to protocol), P4 concentrations were determined on a subset of cows (Day −11, Day −4, Day 7), and ovulatory follicle diameter was evaluated on Day 0. Pregnancy success (P/AI or P/ET) was evaluated on Days 32 and 60. The 2CIDR treatment increased circulating P4 by Day −4 (1.77 ± 0.23 vs. 2.18 ± 0.24 ng/mL) but had no effect on ovulation at the end of protocol (83.6 vs. 82.6%) or ovulatory follicle diameter (15.6 ± 0.3 vs. 15.3 ± 0.3 mm). If only cows that ovulated to the protocol were included, 1CIDR tended to have lower P/AI than 2CIDR by Day 32 (42.8 vs. 52.6%; P = 0.10) and Day 60 (37.7 vs. 48.1%; P = 0.08) but there was no effect on pregnancy loss. There was an interaction (P = 0.05) between ovulatory follicle diameter and CIDR treatment on P/AI (Day 60). In cows ovulating larger follicles (≥14 mm), 2CIDR treatment increased P/AI compared with 1CIDR (53.3 vs. 34.9%; P = 0.02) but not in cows ovulating small follicles (
- Published
- 2017
- Full Text
- View/download PDF
279. Inducible DNA-loop formation blocks transcriptional activation by an SV40 enhancer.
- Author
-
Ameres, Stefan Ludwig, Drueppel, Lars, Pfleiderer, Klaus, Schmidt, Andreas, Hillen, Wolfgang, and Berens, Christian
- Subjects
- *
UTERINE cancer , *GENETIC regulation , *PROTEINS , *BIOMOLECULES , *GENE expression , *NUCLEOPROTEINS - Abstract
It is well established that gene expression in eukaryotes is controlled by sequence-dependent binding of trans-acting proteins to regulatory elements like promoters, enhancers or silencers. A less well understood level of gene regulation is governed by the various structural and functional states of chromatin, which have been ascribed to changes in covalent modification of core histone proteins. And, much on how topological domains in the genome take part in establishing and maintaining distinct gene expression patterns is still unknown. Here we present a set of regulatory proteins that allow to reversibly alter the DNA structure in vivo and in vitro by adding low molecular weight effectors that control their oligomerization and DNA binding. Using this approach, we completely regulate the activity of an SV40 enhancer in HeLa cells by reversible loop formation to topologically separate it from the promoter. This result establishes a new mechanism for DNA-structure-dependent gene regulation in vivo and provides evidence supporting the structural model of insulator function. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
280. A short autonomous repression motif is located within the N-terminal domain of CTCF
- Author
-
Drueppel, Lars, Pfleiderer, Klaus, Schmidt, Andreas, Hillen, Wolfgang, and Berens, Christian
- Subjects
- *
TRANSCRIPTION factors , *PROTEINS , *CYTOMEGALOVIRUS diseases , *HERPESVIRUS diseases - Abstract
The vertebrate transcription factor CTCF is not only involved in transcriptional activation, insulation and genomic imprinting, but also in transcriptional repression. Sequence motifs mediating these activities have not been identified so far. We have mapped a short repression motif to residues 150–170 within the N-terminal domain of CTCF. This motif is active in HeLa, HEK293 and COS-7 cell lines where it is both sufficient and necessary for silencing either an SV40-, or a CMV-enhancer. It also represses the basal activity of an SV40 core promoter. Since this autonomous repression motif displays no sequence similarity to any other regulatory protein, it represents a yet unknown co-repressor recruiting motif. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
281. Genome-Wide Alteration of 5-Hydroxymethylcytosine in Hypoxic-Ischemic Neonatal Rat Model of Cerebral Palsy
- Author
-
Danmei Chen, Yaodong Zhang, Jimin Shi, Chao Gao, Wei Fan, Jihong Zhang, Cuiting Wang, Long Chen, Yunpeng Zhang, and Bing Li
- Subjects
0301 basic medicine ,DNA Hydroxymethylation ,hypoxic-ischemic injury ,Biology ,Bioinformatics ,Temporal lobe ,lcsh:RC321-571 ,Pathogenesis ,03 medical and health sciences ,chemistry.chemical_compound ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,Neurodevelopmental disorder ,DNA hydroxymethylation ,medicine ,5-hydroxymethylcytosine ,Gene ,Molecular Biology ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,Original Research ,5-Hydroxymethylcytosine ,cerebral palsy ,neurodevelopment ,medicine.disease ,Cortex (botany) ,030104 developmental biology ,chemistry ,Signal transduction ,030217 neurology & neurosurgery ,Tet ,Neuroscience - Abstract
Cerebral palsy (CP) is a neurodevelopmental disorder usually occurring early in life and persisting through the whole life. Several risk factors, including perinatal hypoxia-ischemia (HI), may contribute to occurrence of CP in preterm infants. DNA hydroxymethylation has been shown to play an important role in neurodevelopment and neurodegenerative disorders. However, the effect of DNA hydroxymethylation in CP remains unknown. The aim of this study is to explore whether and how DNA hydroxymethylation is involved in CP pathogenesis. We observed that overall 5-hydroxymethylcytosine (5hmC) abundance in the cortex of the temporal lobe of rat pups was decreased significantly after hypoxic-ischemic injury, and the reduced expression of Tet1 and Tet2 enzymes might be responsible for this change. Identified differential hydroxymethylation regions (DhMRs) were richly involved in multiple signaling pathways related to neuronal development and function. Furthermore, we found that reduced 5hmC modification on the DhMRs-related genes were accompanied by decrease of their mRNA expression levels. These results suggest that 5hmC modifications are involved in the CP pathogenesis and may potentially serve as a new therapeutic target.
- Published
- 2019
- Full Text
- View/download PDF
282. MicroRNA Let-7adf in Tet regulation
- Author
-
Shuai Jiang
- Subjects
Lipopolysaccharides ,Aging ,Myeloid ,RNA-binding protein ,Biology ,LIN28 ,Dioxygenases ,Lin28a ,Mice ,MicroRNA Let-7adf ,Proto-Oncogene Proteins ,microRNA ,medicine ,Animals ,myeloid cell ,RNA, Messenger ,Regulation of gene expression ,Mice, Knockout ,H19 ,Effector ,Interleukin-6 ,Macrophages ,RNA ,Succinates ,Cell Biology ,Cell biology ,DNA-Binding Proteins ,Succinate Dehydrogenase ,MicroRNAs ,medicine.anatomical_structure ,Editorial ,Protein Processing, Post-Translational ,Biogenesis ,Tet - Abstract
In our recent work [1], we examined let-7adf to understand pathways that a cell uses to respond to inflammatory signaling. We know myeloid cells are critical to Tet2-mediated IL-6 inhibition. The action of Tet2 is in myeloid cells because a conditional KO and a global KO of Tet2 have similar effects. Our work adds to the previous work [2], which revealed that myeloid cell-specific Tet2-deficient mice were more susceptible to dextran sulfate sodium (DSS)-induced colitis and displayed a more severe inflammatory phenotype than WT mice, with exacerbated colon inflammation including higher production of IL-6. In this work, we discovered a novel regulatory control of Tet2 by let-7adf. Although functional roles of Tet2 in macrophages have been extensively studied, the knowledge of how Tet2 is precisely regulated has been limited. The questions regarding the complicated network of regulation of Tet2 through interaction with the let-7 miR remain open and will be an area of significant interest. The posttranscriptional effectors engaged in the regulation of gene expression, including RNA-binding proteins and other non-coding RNAs, can affect miR-mediated gene regulation. For instance, Lin28 RNA binding protein blocks biogenesis of let-7 miRs [3] and the H19 long non-coding RNA acts as a molecular sponge for the let-7 family of miRs [3]. We would speculate that either Lin28 or H19 might control Tet2 through regulating behavior of let-7 in activated macrophages.
- Published
- 2019
283. DNA methylation instability by BRAF-mediated TET silencing and lifestyle-exposure divides colon cancer pathways
- Author
-
Kaspar Truninger, Faiza Noreen, Taya Küng, Giancarlo Marra, Stefan Weis, Roland Rad, Hannah R Parker, Luigi Tornillo, Miguel Silva, and Primo Schär
- Subjects
0301 basic medicine ,Male ,Aging ,Colorectal cancer ,Mutant ,medicine.disease_cause ,Epigenesis, Genetic ,Mixed Function Oxygenases ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,Gene Regulatory Networks ,Genetics (clinical) ,DNA methylation ,Methylation ,ddc ,Colon cancer ,DNA-Binding Proteins ,030220 oncology & carcinogenesis ,Colonic Neoplasms ,Female ,HT29 Cells ,Proto-Oncogene Proteins B-raf ,Down-Regulation ,Biology ,Dioxygenases ,03 medical and health sciences ,Cell Line, Tumor ,Proto-Oncogene Proteins ,Genetics ,medicine ,Gene silencing ,Animals ,Humans ,Molecular Biology ,Gene ,CIMP ,BRAF V600E ,Research ,Neoplasms, Experimental ,medicine.disease ,digestive system diseases ,030104 developmental biology ,chemistry ,Mutation ,Cancer research ,Caco-2 Cells ,Carcinogenesis ,DNA ,TET ,Developmental Biology - Abstract
BackgroundAberrations in DNA methylation are widespread in colon cancer (CC). Understanding origin and progression of DNA methylation aberrations is essential to develop effective preventive and therapeutic strategies. Here, we aimed to dissect CC subtype-specific methylation instability to understand underlying mechanisms and functions.MethodsWe have assessed genome-wide DNA methylation in the healthy normal colon mucosa (HNM), precursor lesions and CCs in a first comprehensive study to delineate epigenetic change along the process of colon carcinogenesis. Mechanistically, we used stable cell lines, genetically engineered mouse model of mutant BRAFV600Eand molecular biology analysis to establish the role of BRAFV600E-mediated-TET inhibition in CpG-island methylator phenotype (CIMP) inititation.ResultsWe identified two distinct patterns of CpG methylation instability, determined either by age–lifestyle (CC-neutral CpGs) or genetically (CIMP-CpGs). CC-neutral-CpGs showed age-dependent hypermethylation in HNM, all precursors, and CCs, while CIMP-CpGs showed hypermethylation specifically in sessile serrated adenomas/polyps (SSA/Ps) and CIMP-CCs.BRAFV600E-mutated CCs and precursors showed a significant downregulation ofTET1andTET2DNA demethylases. Stable expression ofBRAFV600Ein nonCIMP CC cells and in a genetic mouse model was sufficient to repress TET1/TET2 and initiate hypermethylation at CIMP-CpGs, reversible byBRAFV600Einhibition.BRAFV600E-driven CIMP-CpG hypermethylation occurred at genes associated with established CC pathways, effecting functional changes otherwise achieved by genetic mutation in carcinogenesis.ConclusionsHence, while age–lifestyle-driven hypermethylation occurs generally in colon carcinogenesis,BRAFV600E-driven hypermethylation is specific for the “serrated” pathway. This knowledge will advance the use of epigenetic biomarkers to assess subgroup-specific CC risk and disease progression.
- Published
- 2019
284. Genes Controlled by DNA Methylation Are Involved in Wilms Tumor Progression
- Author
-
Paulo Antônio Silvestre de Faria, Paulo S. Oliveira, Carolina Furtado, Bruna Maria de Sá Pereira, Nicole de Miranda Scherer, Mariana Boroni, Rafaela Montalvão de Azevedo, Jéssica Gonçalves Vieira da Cruz, Beatriz de Camargo, João Victor da Silva Guerra, and Mariana Maschietto
- Subjects
Male ,Genes, Wilms Tumor ,DNMT ,Biology ,Kidney ,Article ,Epigenesis, Genetic ,Gene expression ,medicine ,Humans ,Gene ,lcsh:QH301-705.5 ,data integration ,Regulation of gene expression ,DNA methylation ,Kidney metabolism ,Wilms tumor ,Wilms' tumor ,Promoter ,General Medicine ,Methylation ,medicine.disease ,Molecular biology ,cancer progression ,Kidney Neoplasms ,Gene Expression Regulation, Neoplastic ,lcsh:Biology (General) ,Disease Progression ,gene expression ,Female ,Transcriptome ,TET - Abstract
To identify underlying mechanisms involved with metastasis formation in Wilms tumors (WTs), we performed comprehensive DNA methylation and gene expression analyses of matched normal kidney (NK), WT blastemal component, and metastatic tissues (MT) from patients treated under SIOP 2001 protocol. A linear Bayesian framework model identified 497 differentially methylated positions (DMPs) between groups that discriminated NK from WT, but MT samples were divided in two groups. Accordingly, methylation variance grouped NK and three MT samples tightly together and all WT with four MT samples that showed high variability. WT were hypomethylated compared to NK, and MT had a hypermethylated pattern compared to both groups. The methylation patterns were in agreement with methylases and demethylases expression. Methylation data pointed to the existence of two groups of metastases. While hierarchical clustering analysis based on the expression of all 2569 differentially expressed genes (DEGs) discriminated WT and MT from all NK samples, the hierarchical clustering based on the expression of 44 genes with a differentially methylated region (DMR) located in their promoter region revealed two groups: one containing all NKs and three MTs and one containing all WT and four MTs. Methylation changes might be controlling expression of genes associated with WT progression. The 44 genes are candidates to be further explored as a signature for metastasis formation in WT.
- Published
- 2019
285. Reprogramming the Epigenome With Vitamin C
- Author
-
Taylor Lee Chong, Emily L. Ahearn, and Luisa Cimmino
- Subjects
0301 basic medicine ,vitamin C ,Review ,Biology ,03 medical and health sciences ,Cell and Developmental Biology ,0302 clinical medicine ,cancer ,Epigenetics ,stem cell reprogramming ,Induced pluripotent stem cell ,lcsh:QH301-705.5 ,Cell Biology ,Epigenome ,Jumonji C ,030104 developmental biology ,Histone ,lcsh:Biology (General) ,030220 oncology & carcinogenesis ,DNA methylation ,biology.protein ,Cancer research ,Histone Demethylases ,Stem cell ,Reprogramming ,TET ,Developmental Biology - Abstract
The erasure of epigenetic modifications across the genome of somatic cells is an essential requirement during their reprogramming into induced pluripotent stem cells (iPSCs). Vitamin C plays a pivotal role in remodeling the epigenome by enhancing the activity of Jumonji-C domain-containing histone demethylases (JHDMs) and the ten-eleven translocation (TET) proteins. By maintaining differentiation plasticity in culture, vitamin C also improves the quality of tissue specific stem cells derived from iPSCs that are highly sought after for use in regenerative medicine. The ability of vitamin C to potentiate the activity of histone and DNA demethylating enzymes also has clinical application in the treatment of cancer. Vitamin C deficiency has been widely reported in cancer patients and has recently been shown to accelerate cancer progression in disease models. Therapies involving high-dose vitamin C administration are currently gaining traction in the treatment of epigenetic dysregulation, by targeting aberrant histone and DNA methylation patterns associated with cancer progression.
- Published
- 2019
286. Drosophila Tet Is Expressed in Midline Glia and Is Required for Proper Axonal Development
- Author
-
Joy N. Ismail, Shireen Badini, Felice Frey, Wassim Abou-Kheir, and Margret Shirinian
- Subjects
0301 basic medicine ,midline glia ,axon guidance defect ,Central nervous system ,lcsh:RC321-571 ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,Downregulation and upregulation ,medicine ,Axon ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,Original Research ,Gene knockdown ,biology ,neurodevelopment ,fungi ,axon guidance cue ,biology.organism_classification ,Slit ,Cell biology ,030104 developmental biology ,medicine.anatomical_structure ,nervous system ,Ventral nerve cord ,Axon guidance ,Drosophila ,Drosophila melanogaster ,030217 neurology & neurosurgery ,Tet ,Neuroscience - Abstract
Ten-Eleven Translocation (TET) proteins are important epigenetic regulators that play a key role in development and are frequently deregulated in cancer. Drosophila melanogaster has a single homologous Tet gene (dTet) that is highly expressed in the central nervous system during development. Here, we examined the expression pattern of dTet in the third instar larval CNS and discovered its presence in a specific set of glia cells: midline glia (MG). Moreover, dTet knockdown resulted in significant lethality, locomotor dysfunction, and alterations in axon patterning in the larval ventral nerve cord. Molecular analyses on dTet knockdown larvae showed a downregulation in genes involved in axon guidance and reduced expression of the axon guidance cue Slit. Our findings point toward a potential role for dTet in midline glial function, specifically the regulation of axon patterning during neurodevelopment.
- Published
- 2019
- Full Text
- View/download PDF
287. Perpignan : la Têt et la Basse
- Author
-
Calvet, Marc, Histoire naturelle de l'Homme préhistorique (HNHP), Muséum national d'Histoire naturelle (MNHN)-Université de Perpignan Via Domitia (UPVD)-Centre National de la Recherche Scientifique (CNRS), CARCAUD N., ARNAUD-FASSETTA G & EVIN C., and Centre National de la Recherche Scientifique (CNRS)-Muséum national d'Histoire naturelle (MNHN)-Université de Perpignan Via Domitia (UPVD)
- Subjects
Têt ,Basse ,[SHS.ARCHEO]Humanities and Social Sciences/Archaeology and Prehistory ,Ruscino ,Moyen-Âge ,[SDE]Environmental Sciences ,[SDU.STU.GM]Sciences of the Universe [physics]/Earth Sciences/Geomorphology ,[SHS.GEO]Humanities and Social Sciences/Geography ,Perpignan ,Gallo-romain ,[SDU.STU.AG]Sciences of the Universe [physics]/Earth Sciences/Applied geology ,ComputingMilieux_MISCELLANEOUS - Abstract
International audience
- Published
- 2019
288. Epigenetic and transcriptional profile of bovine skin fibroblasts cultured in vitro with DNA demethylating substances
- Author
-
Naiara Araújo Borges Schumann, Franco, Maurício Machaim, Vieira, Carlos Ueira, Luiz, Denis Prudencio, Vaz, Emília Rezende, and Goulart, Vivian Alonso
- Subjects
Cloning ,CIENCIAS BIOLOGICAS::GENETICA [CNPQ] ,CIENCIAS BIOLOGICAS::GENETICA::GENETICA ANIMAL [CNPQ] ,Metilação ,DNMT ,TNCS ,DNA ,Biology ,Expressão gênica ,Molecular biology ,chemistry.chemical_compound ,CIENCIAS BIOLOGICAS [CNPQ] ,chemistry ,SAH ,Somatic cell nuclear transfer ,Clonagem ,Epigenetics ,Epigenética ,Procaína ,TET - Abstract
CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior A clonagem via transferência nuclear de células somáticas (TNCS) é uma biotécnica de reprodução assistida em uso comercial, com várias aplicações. Ainda assim é uma técnica de baixa eficiência, possivelmente em consequência do perfil epigenético do genoma somático da célula doadora de núcleo, o que dificulta a reprogramação correta após a transferência nuclear. A memória epigenética da célula diferenciada resulta em alterações na expressão de genes importantes durante o desenvolvimento embrionário. Nesse estudo, analisamos o perfil de metilação do DNA e de expressão gênica de fibroblastos bovinos cultivados in vitro com drogas desmetilantes de DNA, S-Adenosil-L-Homocisteína e procaína. Com relação ao perfil epigenético, foram quantificados os níveis globais de metilação do DNA, bem como os níveis de metilação em uma região de DNA repetitivo. Além disso, foram produzidos embriões e avaliados os níveis de metilação destes para duas regiões repetitivas satélites. Quanto ao perfil de expressão gênica, determinamos os níveis de mRNA para os genes DNMT1, DNMT3A, DNMT3B, TET1, TET2, TET3 e OCT4, os quais estão relacionados à reprogramação da metilação do DNA e estado de pluripotência. Células tratadas com as substâncias desmetilantes apresentaram níveis menores de metilação do DNA, tanto a nível global quanto para a região satélite I. Os embriões clones produzidos a partir de células tratadas apresentaram menores níveis de metilação em relação aos embriões controles para a região Satelite I. Quanto ao perfil transcricional, verificamos que células tratadas com SAH+procaína, apresentaram redução geral nos níveis de DNMTs. Por outro lado, para a enzima TET3 foi observado maior nível de transcritos em comparação ao controle. Nossos resultados mostraram que o uso desses agentes desmetilantes em células doadoras de núcleo foi capaz de alterar os níveis de metilação do DNA, além de alterar o perfil transcricional dos genes envolvidos na maquinaria epigenética. Portanto, sugere-se que o uso dessas substâncias possa contribuir para que o ovócito consiga reprogramar o núcleo doador de uma forma mais eficiente após a transferência nuclear. Assim, sugerimos que o uso de agentes moduladores de cromatina nos protocolos de cultivo celular para uso na clonagem por transferência nuclear possa contribuir para melhorar a eficiência da técnica. Somatic cell nuclear transfer (SCNT) is a commercially available technique of assisted reproductive technology with broad applications. It is still a low-efficiency technique, possibly as a consequence of the epigenetic profile of the somatic genome of the donor cell, which carries characteristic marks of differentiated cells, which hampers correct reprogramming after nuclear transfer. This differentiated cell memory leads to changes in DNA methylation patterns as well as changes in the gene expression profile of important genes during embryonic development. In this study, we analyzed the DNA methylation and gene expression profile of bovine fibroblasts cultured in vitro with DNA toxicity drugs of low toxicity, SAH and procaine. Regarding the epigenetic profile, the global levels of DNA methylation were quantified as well as the levels of methylation in a satellite repetitive region of the treated cells. In addition, embryos were produced and their methylation levels were evaluated for two repetitive satellite regions. Regarding the gene expression profile, we determined the mRNA levels for the DNMT1, DNMT3A, DNMT3B, TET1, TET2, TET3 and OCT4 genes, which are related to the reprogramming of DNA methylation and pluripotency state. Cells treated with DNA demethylating substances showed lower levels of DNA methylation, both globally and in the satellite region. The embryonic clones produced from treated cells had lower levels of methylation compared to control embryos for the Satelite I region. Regarding the transcriptional profile, we observed that in cells treated with SAH + procaine, they presented a general reduction in the levels of DNMTs. On the other hand, for the TET3 enzyme, a higher level of transcripts was observed in comparison to the control. Our results showed that the use of demethylating agents in nucleating donor cells is capable of altering their epigenetic profile, in order to modify at the transcriptional level the production of enzymes related to methylation, which can lead the cell to a state of less differentiation. We have discussed, in this research study, the use of chromatin modulating agents as a perspective for use in cloning, medical research in cancer and other diseases. Tese (Doutorado)
- Published
- 2019
289. Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells
- Author
-
Angelika Holler, Gavin M. Bendle, Pedro Veliça, Hans J. Stauss, and Ahdab AlSaieedi
- Subjects
0301 basic medicine ,lcsh:Immunologic diseases. Allergy ,medicine.medical_treatment ,il-12 ,engineering ,Immunology ,adoptive ,lcsh:RC254-282 ,03 medical and health sciences ,0302 clinical medicine ,In vivo ,medicine ,Immunology and Allergy ,t cells ,Original Research ,tcr ,tet ,Doxycycline ,Effector ,business.industry ,T-cell receptor ,Cancer ,NFAT ,Immunotherapy ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,nfat ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Interleukin 12 ,Cancer research ,immunotherapy ,business ,lcsh:RC581-607 ,medicine.drug - Abstract
We explored whether engineering of T cell specificity and effector function improves immunotherapy of solid tumors. Although IL-12 can enhance cancer immunity, a strategy of safe IL-12 delivery without toxicity is currently lacking. We engineered T cells to express IL-12 controlled by the NFAT promoter responsive to TCR stimulation, or by the Tet-On promoter responsive to doxycycline. In vivo, NFAT-engineered T cells caused lethal toxicity, while Tet-engineered T cells were safe in the absence of doxycycline. Combining gene transfer of the melanoma-specific TRP2-TCR with Tet-IL-12 engineering revealed that temporal induction of IL-12 was essential to inhibit the growth of B16F10 melanoma tumors. Induced IL-12 increased the number of tumor-infiltrating T cells and also prevented the down-modulation of the TRP2-TCR and the associated up-regulation of the PD1 marker that was observed in the absence of IL-12. In addition, temporal induction of IL-12 expression also increased the number of plasmacytoid DC in the tumor micro-environment. We show that repeated induction of IL-12 can be used to enhance control of tumor growth without encountering systemic toxicity. The observation that TCR engineering combined with Tet-regulated IL-12 expression can achieve tumor immunity without the side effects that are usually associated with the in vivo use of IL-12 warrants translation of this concept into the clinic.
- Published
- 2019
290. Perfil epigenético e transcricional de fibroblastos isolados de pele bovina cultivados in vitro com substâncias desmetilantes de DNA
- Author
-
SCHUMANN, N. A. B.
- Subjects
SCNT ,Epigenétic ,DNMT ,Metilação ,TNCS ,DNA ,Expressão gênica ,Methylation ,SAH ,Clonagem ,Epigenetics ,Gene expression ,Procaína ,TET ,Procaine ,Cloning - Abstract
Made available in DSpace on 2019-10-31T18:13:23Z (GMT). No. of bitstreams: 1 PerfilEpigeneticoETranscricional.pdf: 2945964 bytes, checksum: 078b8cb08bb2226c0f3a664f1636a3a2 (MD5) Previous issue date: 2019 Tese (Doutorado em Genética e Bioquímica) - Universidade Federal de Uberlândia, MG. Orientador: Maurício Machaim Franco, Embrapa Recursos Genéticos e Biotecnologia.
- Published
- 2019
291. STATEMENT BY THE PRIME MINISTER ON VIETNAMESE NEW YEAR
- Subjects
Tet ,Prime ministers ,News, opinion and commentary - Abstract
OTTAWA, Canada -- The following information was released by the office of the Prime Minister of Canada: The Prime Minister, Justin Trudeau, today issued the following statement on the Vietnamese [...]
- Published
- 2020
292. CORNYN RELEASES LETTER TO TEXANS IN ADVANCE OF TET NGUYEN DAN
- Subjects
Tet ,News, opinion and commentary - Abstract
WASHINGTON -- The following information was released by Texas Senator John Cornyn: U.S. Senator John Cornyn (R-TX) released the following open letter to Texans in honor of Tet Nguyen Dan, [...]
- Published
- 2020
293. Vietnamese New Year: 5 Lucky Dishes You Should Eat For Tet Nguyen Dan
- Published
- 2020
294. Current Landscape of Immunotherapy Trials Involving the Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Axis in Intrathoracic Tumors
- Author
-
Suraj Samtani, Samuel A. Kareff, Vinay Prasad, Chul Kim, and Mauricio Burotto
- Subjects
Mesothelioma ,Pulmonary and Respiratory Medicine ,Oncology ,Drug ,medicine.medical_specialty ,medicine.medical_treatment ,media_common.quotation_subject ,NSCLC ,PD-(L)1 axis ,Programmed cell death 1 ,Internal medicine ,Medicine ,RC254-282 ,media_common ,Chemotherapy ,biology ,business.industry ,SCLC ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Immunotherapy ,medicine.disease ,Blockade ,Clinical trial ,biology.protein ,Original Article ,business ,Adjuvant ,TET - Abstract
Introduction The clinical successes seen with anti–programmed cell death protein 1/programmed death-ligand 1 (anti–PD-[L]1) agents have galvanized the field of immuno-oncology. We evaluated the landscape and trends in immunotherapy trials involving the PD-(L)1 axis in intrathoracic tumors. Methods We identified clinical trials involving anti–PD-(L)1 agents on the ClinicalTrials.gov registry through November 13, 2020 for NSCLC, SCLC, mesothelioma, and thymic epithelial tumor. Clinical trials were indexed according to monotherapy versus combination approaches, PD-(L)1 agents under investigation, clinical settings, trial start date, and partner drug(s). We assessed redundancy among the clinical trials. Results We found 686 clinical trials investigating anti–PD-(L)1 agents for intrathoracic tumors (540 trials in NSCLC, 96 in SCLC, 38 in mesothelioma, and 12 in thymic epithelial tumor). A total of 23 PD-(L)1 inhibitors are undergoing clinical development. A total of 81% of trials assess combination treatment. The number of clinical trials has been growing exponentially in the past decade. PD-(L)1 blockade was frequently combined with chemotherapy or immunomodulatory therapy. Various strategies are in development to overcome resistance to PD-(L)1 blockade in metastatic NSCLC. PD-(L)1 blockade is also increasingly evaluated in neoadjuvant and adjuvant settings. After the U.S. Food and Drug Administration's approval of an anti–PD-(L)1 agent for a specific indication, 14 trials were launched thereafter, which continued to randomize patients to treatments that were inferior to the best available therapy. Conclusions The number of clinical trials investigating anti–PD-(L)1 agents in intrathoracic tumors has experienced a steep increase over the past decade with a notable upward trend for combination trials. To reduce duplicative research efforts and accelerate the development of effective immunotherapeutics, improved coordination among key stakeholders and the adoption of innovative trial designs will be vital.
- Published
- 2021
- Full Text
- View/download PDF
295. Evidence for TET-mediated DNA demethylation as an epigenetic alteration in cumulus granulosa cells of women with polycystic ovary syndrome.
- Author
-
Sagvekar P, Shinde G, Mangoli V, Desai SK, and Mukherjee S
- Subjects
- Cumulus Cells metabolism, DNA, DNA Demethylation, DNA Methylation genetics, Epigenesis, Genetic, Female, Humans, Mixed Function Oxygenases genetics, Mixed Function Oxygenases metabolism, Proto-Oncogene Proteins genetics, Polycystic Ovary Syndrome genetics, Polycystic Ovary Syndrome metabolism
- Abstract
Peripheral and tissue-specific alterations in global DNA methylation (5-methylcytosine (5mC)) and DNA hydroxymethylation (5-hydroxymethylcytosine (5hmC)) profiles have been identified as both biomarkers for disease prediction and as hallmarks of dysregulated localized gene networks. Global and gene-specific epigenetic alterations in the 5mC profiles have shown widespread implications in the etiology of polycystic ovary syndrome (PCOS). However, there has been no study in PCOS that integrates the quantification of 5mC and 5hmC signatures alongside the expression levels of DNA methylating and demethylating enzymes as respective indicators of methylation and demethylation pathways. Having previously shown that the 5mC signatures are not substantially altered in PCOS, we assessed the global 5hmC levels in peripheral blood leukocytes and cumulus granulosa cells (CGCs) of 40 controls and 40 women with PCOS. This analysis revealed higher 5hmC levels in CGCs of PCOS women, indicating a more dominant demethylation pathway. Furthermore, we assessed the transcript and protein expression levels of DNA demethylating and methylating enzymes, i.e. ten-eleven translocation methylcytosine dioxygenases (TET1, TET2, TET3) and DNA methyltransferases (DNMT1, DNMT3A and DNMT3B), respectively, in CGCs. The relative transcript and protein expression levels of all three TETs were found to be higher in women with PCOS, and the TET mRNA expression profiles were positively correlated with 5hmC levels in CGCs. Also, all three DNMT genes showed altered transcript expression in PCOS, although only the downregulated DNMT3A transcript was correlated with decreasing 5mC levels. At the protein level, the expression of DNMT1 (maintenance methylation enzyme) was higher, while that of DNMT3A (de novo methylation enzyme) was found to be lower in PCOS compared to controls. Overall, these results indicate that DNA methylation changes in CGCs of PCOS women may arise partly due to intrinsic alterations in the transcriptional regulation of TETs and DNMT3A., (© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
296. Tet Enzymes-Mediated DNA 5hmC Modification in Cerebral Ischemic and Hemorrhagic Injury.
- Author
-
Ma X, Yang B, Li X, and Miao Z
- Subjects
- DNA genetics, DNA metabolism, Humans, Ischemia genetics, DNA Methylation, Stroke genetics
- Abstract
5-Hydroxymethylcytosine (5hmC) has recently been found that plays an important role in many diseases; however, there are still few studies in the field of stroke. The purpose of this review is to introduce the influence and function of 5hmC in stroke, in order for more people can study it. In this review, we introduced the role of 5hmC in ischemia and hemorrhage stroke, and summarized the possible therapeutic prospects of 5hmC in stroke. In conclusion, we suggest that 5hmC may serve as a biomarker or therapeutic target for the treatment of stroke., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
297. TET-mediated DNA hydroxymethylation is negatively influenced by the PARP-dependent PARylation.
- Author
-
Tolić A, Ravichandran M, Rajić J, Đorđević M, Đorđević M, Dinić S, Grdović N, Jovanović JA, Mihailović M, Nestorović N, Jurkowski TP, Uskoković AS, and Vidaković MS
- Subjects
- DNA metabolism, DNA Methylation, DNA Repair, Poly ADP Ribosylation, Poly(ADP-ribose) Polymerase Inhibitors pharmacology
- Abstract
Background: Poly(ADP-ribosyl)ation (PARylation), a posttranslational modification introduced by PARP-1 and PARP-2, has first been implicated in DNA demethylation due to its role in base excision repair. Recent evidence indicates a direct influence of PARP-dependent PARylation on TET enzymes which catalyse hydroxymethylation of DNA-the first step in DNA demethylation. However, the exact nature of influence that PARylation exerts on TET activity is still ambiguous. In our recent study, we have observed a negative influence of PARP-1 on local TET-mediated DNA demethylation of a single gene and in this study, we further explore PARP-TET interplay., Results: Expanding on our previous work, we show that both TET1 and TET2 can be in vitro PARylated by PARP-1 and PARP-2 enzymes and that TET1 PARylation negatively affects the TET1 catalytic activity in vitro. Furthermore, we show that PARylation inhibits TET-mediated DNA demethylation at the global genome level in cellulo., Conclusions: According to our findings, PARP inhibition can positively influence TET activity and therefore affect global levels of DNA methylation and hydroxymethylation. This gives a strong rationale for future examination of PARP inhibitors' potential use in the therapy of cancers characterised by loss of 5-hydroxymethylcytosine., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
298. The chromatin remodelling protein LSH/HELLS regulates the amount and distribution of DNA hydroxymethylation in the genome.
- Author
-
De Dieuleveult M, Bizet M, Colin L, Calonne E, Bachman M, Li C, Stancheva I, Miotto B, Fuks F, and Deplus R
- Subjects
- 5-Methylcytosine metabolism, Animals, Cytosine metabolism, DNA metabolism, DNA Helicases metabolism, Fibroblasts metabolism, Genome, Mice, Chromatin Assembly and Disassembly, DNA Methylation
- Abstract
Ten-Eleven Translocation (TET) proteins convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) leading to a dynamic epigenetic state of DNA that can influence transcription and chromatin organization. While TET proteins interact with complexes involved in transcriptional repression and activation, the overall understanding of the molecular mechanisms involved in TET-mediated regulation of gene expression still remains limited. Here, we show that TET proteins interact with the chromatin remodelling protein lymphoid-specific helicase (LSH/HELLS) in vivo and in vitro . In mouse embryonic fibroblasts (MEFs) and embryonic stem cells (ESCs) knock out of Lsh leads to a significant reduction of 5-hydroxymethylation amount in the DNA. Whole genome sequencing of 5hmC in wild-type versus Lsh knock-out MEFs and ESCs showed that in absence of Lsh , some regions of the genome gain 5hmC while others lose it, with mild correlation with gene expression changes. We further show that differentially hydroxymethylated regions did not completely overlap with differentially methylated regions indicating that changes in 5hmC distribution upon Lsh knock-out are not a direct consequence of 5mC decrease. Altogether, our results suggest that LSH, which interacts with TET proteins, contributes to the regulation of 5hmC levels and distribution in MEFs and ESCs.
- Published
- 2022
- Full Text
- View/download PDF
299. A Survey on Applications of H-Technique: Revisiting Security Analysis of PRP and PRF.
- Author
-
Jha A and Nandi M
- Abstract
The Coefficients H technique (also called the H-technique), developed by Patarin circa 1991, is a tool used to obtain the upper bounds on distinguishing advantages. This tool is known to provide relatively simple and (in some cases) tight bound proofs in comparison to some other well-known tools, such as the game-playing technique and random systems methodology. In this systematization of knowledge (SoK) paper, we aim to provide a brief survey on the H-technique. The SoK is presented in four parts. First, we redevelop the necessary nomenclature and tools required to study the security of any symmetric-key design, especially in the H-technique setting. Second, we provide a full description of the H-technique and some related tools. Third, we present (simple) H-technique-based proofs for some popular symmetric-key designs, across different paradigms. Finally, we show that the H-technique can actually provide optimal bounds on distinguishing advantages.
- Published
- 2022
- Full Text
- View/download PDF
300. LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond.
- Author
-
Huang W, Li H, Yu Q, Xiao W, and Wang DO
- Subjects
- Humans, DNA Methylation genetics, Neoplasms genetics, RNA, Long Noncoding metabolism
- Abstract
DNA methylation is one of the most important epigenetic mechanisms to regulate gene expression, which is highly dynamic during development and specifically maintained in somatic cells. Aberrant DNA methylation patterns are strongly associated with human diseases including cancer. How are the cell-specific DNA methylation patterns established or disturbed is a pivotal question in developmental biology and cancer epigenetics. Currently, compelling evidence has emerged that long non-coding RNA (lncRNA) mediates DNA methylation in both physiological and pathological conditions. In this review, we provide an overview of the current understanding of lncRNA-mediated DNA methylation, with emphasis on the roles of this mechanism in cancer, which to the best of our knowledge, has not been systematically summarized. In addition, we also discuss the potential clinical applications of this mechanism in RNA-targeting drug development., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.